INTRODUCTION
Acellular scaffolds functionalized with cell-stimulatory molecules are widely used in tissue-engineering (1) (2) (3) (4) . This approach relies on endogenous cells to populate the scaffold following surgical implantation. Matching the timescale of the release of the cell-stimulatory molecules from the scaffold with the invasion kinetics of endogenous cells into the scaffold would presumably be important.
For cartilage repair, microfracture surgery is used in part to access the endogenous progenitor cell population, but the resulting repair tissue is often mechanically inferior fibrocartilage, and lateral integration with native cartilage can be incomplete (5, 6) . In vitro and in vivo studies have shown that the addition of cell-free scaffolds functionalized with growth factors(GFs) may help induce chondrogenesis of endogenous progenitor cells, neotissue production by these cells, and subsequent integration of neotissue with host tissue (1, (7) (8) (9) (10) (11) (12) (13) (14) (Fig. 1A) .
One candidate class of scaffolds for augmenting microfracture is self-assembling peptide hydrogels (15, 16) . These injectable hydrogels assemble upon exposure to physiological pH and ionic strength at concentrations less than 0.5%, allowing ample space for cells to deposit neotissue. The self-assembling sequences KLD and RAD have been shown to foster chondrogenesis of bone marrow progenitor cells and matrix production by primary chondrocytes (13, 16, 17) . Once assembled, acellular KLD has an equilibrium modulus of ~1kPa, while chondrocyte-seeded KLD supports the assembly of functional neo-tissue with a modulus of ~95kPa after 4 weeks of culture (16, 18) . Initial in vivo studies demonstrated KLD to both be biocompatible and show promise towards stimulating repair (1, 19) .
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Many pro-anabolic GFs have been investigated in tissue engineering approaches to stimulate growth, such as insulin-like growth factor-1(IGF-1) in the case of cartilage tissue (20, 21) , vascular endothelial growth factor(VEGF) for cardiac tissue (4, 22, 23) , fibroblastic growth factor-2(FGF-2) and nerve growth factor(NGF) for neural tissue (24) , and epidermal growth factor(EGF) for hepatic tissue (24) . Growth factors are also frequently used to stimulate progenitor cell differentiation in vitro, such as transforming growth factor beta-1(TGF-1) to stimulate chondrogenesis of mesenchymal progenitor cells (25) . When pharmacologically delivered to the body globally, however, some GFs, such as IGF-1, can trigger systemic adverse events (26) (27) (28) . Local delivery of such GFs by functionalization to scaffolds or particles (24, 29) , encapsulation in microspheres (20, 30) , or the development of fusion proteins (31) have extended the viability of these GFs as useful tissue engineering tools. The fusion protein heparinbinding insulin-like growth factor-1(HB-IGF-1), for example, stimulates matrix production by chondrocytes through a single dose delivered via a self-assembling peptide hydrogel scaffold (13, 31) . Such local delivery allows for lower doses than injection methods, reducing toxicity and costs.
Despite these promising in vitro results with locally delivered anabolic growth factors, it is believed that the benefits of these anabolic GFs will not be realized if the GFs diffuse out of the acellular scaffold prior to endogenous progenitor cell invasion in vivo.
We therefore hypothesized that the addition of chemotactic GFs to the scaffold accelerates the migration of endogenous cells into the scaffold, providing potential enhanced benefit from the anabolic GFs. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Previous studies by Ozaki et al., Fiedler et al. , and others, using modified Boyden chamber assays, have shown generally that mesenchymal stem cell chemotaxis can be stimulated by platelet derived growth factor-BB(PDGF-BB), and this effect is enhanced when combined with IGF-1 or transforming growth factor (TGF-) (32) (33) (34) (35) (36) (37) . Thus, we further hypothesized that the addition of PDGF-BB to our self-assembling peptide hydrogel scaffold provides a synergistic chemotactic effect with a pro-chondrogenic member of the TGF-family, TGF-1, or the pro-anabolic GF HB-IGF-1.
Building upon the detailed literature characterizing KLD as a suitable environment for progenitor cell chondrogenesis and chondrocyte matrix production, this work focuses on assessing KLD as an environment for GF-induced migration (17, (38) (39) (40) (41) . We hypothesized that the addition of pro-migratory GFs to KLD would result in increased cell migration into the gel. To test our hypothesis, we developed a novel 3D gel-to-gel migration system and used this system to evaluate the chemotactic impact of GFs on progenitor cells in KLD( Fig. 1B) (42) . Specifically, using a cell population relevant to the endogenous cells accessed during microfracture, we studied the effects of the GFs PDGF-BB, TGF-1, and HB-IGF-1(individually and in combination) for their chemotactic potential in our 3D hydrogel scaffold. Further, we quantified the release kinetics of the candidate GFs from the scaffold in order to interpret their participation in cell migration.
II. MATERIALS & METHODS

Cell harvest, expansion, and encapsulation:
Since the cells accessed in microfracture surgery reside below the microfracture punctures, we isolated progenitor This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
cells isolated from the stroma associated with subchondral trabecular bone.
Mesenchymal progenitor cells associated with the marrow stroma found in immature trabecular bone(BM-PCs) were isolated from the subchondral trabecular bone of 1-2
week old bovine calf knee joints in a manner modified from Haynesworth et al. and Li et al. (43, 44) fragments were rinsed vigorously with this medium and vortexed to mechanically drive out the cells. The resulting cell suspension was filtered through a 70µm-pore strainer and plated in flasks at 2.5x10 5 cells/cm 2 in expansion medium for 24 hours. The medium was removed and replenished, and cells were cultured until primary colonies reached 80% confluence( Fig. 2C ). BM-PC colonies were removed from flasks with 0.05% trypsin in 0.53mM EDTA(Corning, Corning, NY), and frozen until further use. BM-PCs were passaged 1-2 times by plating with a seeding density of 1x10 3 cells/cm 2 in expansion medium containing 5ng/mL FGF-2 and expanding until 80-90% confluent. These expanded BM-PCs were encapsulated in 3.5mg/mL KLD self-assembling peptide hydrogels at 10x10 6 cells/mL, as described previously (17) , for use in matrix production This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. and migration studies. For matrix production studies, the cell-seeded hydrogels were cultured in chondrogenic culture medium consisting of high glucose DMEM, 1% insulin- 
Analysis of matrix production and cell proliferation: Thorough characterization of the chondrogenic capacity of bone marrow progenitor cells in KLD was previously
reported by our lab, including both immunohistochemistry of collagen types I and II, as well as qPCR for the temporal evolution of gene expression for collagens types I & II, aggrecan, SOX9, osteocalcin and PPAR- (17) . We also measured toluidine blue staining, sGAG production, and hydroxyproline content, and confirmed that these measures provided complementary surrogate markers of matrix production by chondrogenic cells (17, 38) . At day 22 in the present study, synthesis rates of sGAG and total protein were assessed by radiolabel incorporation using 5µCi of 35 S-sulfate and 10µCi of 3 H-proline(Perkin Elmer, Waltham, MA), respectively(46); total sGAG output was measured by DMMB dye binding, collagen content was measured by hydroxyproline reaction with p-dimethylaminobenzaldehyde, and DNA content was measured by Hoechst dye binding, as described previously (47) (48) (49) . Histological staining for the spatial appearance of sGAG using toluidine blue was performed as described previously (16, 17) . N=6-8 gels per time point.
Gel-to-gel migration assay:
We developed a novel gel-to-gel migration assay shown schematically in Fig 
PDGF-BB loading efficiency in KLD hydrogels:
A radiolabeled form of PDGF-BB( 125 I-PDGF-BB)(Perkin Elmer) was used to assess its entrapment in KLD, following a method described previously for a similar self- This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. and bath, gels, and tubes were counted via gamma counter for 2 minutes. Using similar methods, entrapment of TGF-1 in KLD was previously characterized by Kopesky et al.
using 125 I-TGF-1(Perkin Elmer, Waltham, MA) (40) , and entrapment of HB-IGF-1 in the similar self-assembling peptide hydrogel RAD was previously characterized by Florine et al. (13) . gels were cast at the bottom of autoclaved low-retention tubes. Assembly was initiated with PBS + 1% PSA(n=14). Gels were incubated at 37C at 5% CO 2 on a rotary shaker, and bath aliquots were removed and replenished every 1-2 days for 2 weeks. Aliquots, gels, and tubes were counted via gamma counter for 2 minutes following the two-week incubation. 14 C-HB-IGF-1: The release profile of HB-IGF-1 from KLD was determined as described previously for the similar self-assembling peptide hydrogel RAD (13) . Briefly, 14 C-HB-IGF-1 was mixed with acellular KLD prior to gel assembly at a final GF concentration of 615nM, and PBS + 1% PSA was added to trigger self-assembly. Gels This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
GF release from KLD hydrogels:
were incubated at 37C, and bath samples were removed and replenished every 24
hours for the first 8 days, and every 48 hours for days [8] [9] [10] [11] [12] [13] [14] [15] [16] . On day 16, baths were removed, gels were mechanically disrupted, and radiolabeled protein was measured in bath and gel samples by liquid scintillation counting.
Statistical analyses:
Values are mean ± SEM. Comparisons use general linear mixed effects models and Tukey's HSD post hoc test(p<0.05), (JMP 11, SAS, Inc., Cary, NC).
III. RESULTS
BM-PC matrix production and cell proliferation:
We assessed the matrix production capacity of both passage-1(P1) BM-PCs and passage-2(P2) BM-PCs, to determine if four additional population doublings altered their ability to produce matrix. Histological assessment of P2 BM-PCs encapsulated in KLD hydrogels with toluidine blue for sGAG following 22 days of culture showed strong, disperse staining, indicative of high proteoglycan content (Fig. 3) . Both P1 and P2 BM-PCs continued to proliferate following hydrogel encapsulation (Fig. 4A ). Both populations also showed robust sGAG synthesis and deposition (Fig. 4B, C) , along with increasing collagen deposition over the time course of the study (Fig. 4D ). Previous studies using bovine BMSCs in KLD scaffolds have shown a similar evolution of sGAG synthesis and deposition, and the sGAG to be associated predominantly with aggrecan production (17) . Together these data suggest a chondrogenic potential that is consistent with previous studies using BMSCs derived from cortical bone marrow (17, 39) .
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GF-stimulated gel-to-gel BM-PC migration:
To assess the ability of BM-PCs to invade a GF-loaded gel, BM-PCs were encapsulated in a second gel atop the first( Fig   1B) . The mean position of the green fluorescent beads in the construct was used to demark the interface between the two gels. Cells that moved beyond one standard deviation past the mean bead position into the bottom gel were considered to have migrated, and the subset of cells that moved beyond two such standard deviations were considered to have migrated strongly( Fig. 5 ). All 8 combinations of TGF-1, PDGF-BB, and HB-IGF-1 were tested for their impact on BM-PC migration in KLD hydrogels. The combination of TGF-1 and PDGF-BB induced statistically significant migration compared to the GF-free control, whereas increases seen with all other GF combinations were not statistically significant (Fig. 6 ). The percent of cells that migrated strongly under the combination treatment of TGF-1 and PDGF-BB was significantly higher than for TGF-1 alone, HB-IGF-1 alone, or the combination of PDGF-BB and HB-IGF-1, while the percent of cells that migrated strongly under the PDGF-BB treatment was significantly higher than the combination of PDGF-BB and HB-IGF-1.
Entrapment of 125 I-PDGF-BB in acellular KLD:
To determine the initial entrapment efficiency of PDGF-BB in unassembled KLD, a mixture of 125 I-PDGF-BB and PDGF-BB at a final concentration of 335ng/mL was added to KLD at a final concentration of 3.5mg/mL of peptide(see Methods). Three hours after initiation of gel assembly, 80% of the PDGF-BB initially loaded was entrapped in the gel.
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Release of 14 C-HB-IGF-1 and 125 I-PDGF-BB from acellular KLD:
To assess the release kinetics of HB-IGF-1 and PDGF-BB from KLD, we loaded 14 C-HB-IGF-1 and 125 I-PDGF-BB into unassembled KLD. We measured the release of the radioactive proteins into the bath over 2 weeks, as well as their final presence in the gel at 2 weeks, via scintillation counting for 14 C and gamma counting for 125 I (Fig. 7) . The release profile of TGF-1 from KLD, published by Kopesky et al. (40) , is included in Figure 7 for comparison. A first-order exponential of the form was fit to the release data to obtain a characteristic release time for each growth factor( Table 1 ). These data show that HB-IGF-1 is largely released from KLD within four days, while PDGF-BB is released more slowly and 15% still resides in the gel at two weeks. Separate experiments confirmed that PDGF-BB had little or no effect on cell viability, sGAG content or loss, or the biosynthesis of sGAG or total protein in adjacent cartilage tissue (see supplemental figures 2 & 3).
IV. DISCUSSION
Stimulus of tissue regeneration, mediated by acellular scaffolds functionalized
with GFs, is thought to hinge on matched kinetics between endogenous cell recruitment into the scaffold and GF retention time in the scaffold. Motivated by an augmented microfracture strategy for cartilage repair, we developed a 3D gel-to-gel migration assay to test the chemotactic effect of GFs on BM-PCs. We demonstrated that the combination of PDGF-BB and TGF-1 stimulates migration of BM-PCs into and through a 3D self-assembling peptide hydrogel scaffold when delivered as a single dose premixed into the scaffold (Fig 6) . A single premixed dose allows for easy translation to an in vivo surgical setting, but it raises the question of GF retention and release kinetics from the scaffold in order to bind to cell receptors once cells have entered the scaffold.
Entrapment efficiency of PDGF was ~80%, suggesting that a significant amount of PDGF remained in the gel, consistent with previous results for TGF-1 (40) . We measured GF release kinetics and showed that the characteristic exponential release time of PDGF-BB from KLD(in the geometry of Fig. 1B) to be 3.5 days, with 58% of the loaded PDGF-BB remaining in the scaffold at the 4-day time point of our 3D gel-to-gel migration studies (Table 1 ). Previous studies have shown even stronger retention of TGF-1 in KLD (40) . The substantial release of HB-IGF-1 from KLD indicates that a strong gradient of HB-IGF-1 was no longer present in our in vitro system after 4 days.
Thus, chemotaxis induced by conditions containing HB-IGF-1 should not be expected in the geometry of Fig. 1B , despite the chemotactic properties previously reported for the IGF family of proteins in modified Boyden chamber assays using BMSCs (32, 35) . The range of release profiles observed between the three GFs reflects how they each interact with the scaffold in a unique manner, though the precise mechanistic differences in scaffold-GF interactions have not been elucidated. There are no known specific binding motifs between any of these three GFs and KLD, although factors that may impact these differences include size, amino acid content and sequence, conformation, net charge, and non-specific binding. Taken together, these data demonstrate that KLD scaffolds possess GF release kinetics that may effectively stimulate migration of BM-PCs in the scaffold while retaining a portion of GFs that may subsequently promote cartilage repair by localized BM-PCs in vivo. 
Both synergistic and antagonistic interactions between PDGF-BB and TGF-1
have been shown previously in a variety of cell/tissue systems, including murine embryos (53) , human pulmonary smooth muscle cells (54) , and murine wound healing(55). In our system, neither PDGF-BB nor TGF-1 was able to induce statistically significant migration alone. These data are consistent with the murine embryo study by Wang et al., which demonstrated that sclerotome and surrounding mesenchyme cells require PDGF signaling for TGF-1 mediated migration. The precise mechanism of action that describes how these GFs together induce migration of BM-PCs is not yet known, and would require quantification of migratory-associated cell signaling pathways; while beyond the scope of this study, such experiments are underway.
Studies by Steadman et al. and others have theorized that one cause for the formation of fibrocartilage rather than hyaline cartilage following microfracture surgery may be an insufficient quantity of progenitor cells populating the defect in the initial days post-surgery (56) (57) (58) (59) . Our strategy of growth factor-mediated acceleration of progenitor cell migration may have the potential to increase the number of cells recruited to a scaffold-filled defect in augmented microfracture surgery, and thereby increase the likelihood of hyaline cartilage production both through higher cellularity and growth factor-enhanced matrix synthesis.
The data presented here, combined with data from the literature, show that both PDGF-BB and TGF-1 are retained within KLD at significant levels over the 4 day period during which our migration studies were performed(40) (Fig 7) . To induce directed cell migration, cells must be exposed to gradients in chemotactic factors rather than a This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
bolus release (60, 61) . Our results imply that the release kinetics of PDGF-BB and TGF- While the complex cell population accessed in microfracture surgery presents a challenge for experimental models, bone marrow-derived mesenchymal progenitor cells are commonly used in vitro to simulate them (66) (67) (68) (69) (70) . To isolate BM-PCs, bone marrow stroma is typically scooped from the diaphyseal marrow cavity of long bones, aspirated from the iliac crest, or separated from sponge-like network of trabecular bone (43, 68) .
These techniques have also been successfully applied to an array of species, including human, canine, feline, porcine, lapine, and bovine (43, (71) (72) (73) (74) (75) (76) (77) . Regardless of the physiological location of marrow harvested, these techniques all yield progenitor cells capable of undergoing chondrogenesis, whether in pellet culture or 3D scaffolds, such as KLD (17, 39, 44, 66, 68, 70, (77) (78) (79) (80) . While a phenotypic characterization of the cell population accessed in microfracture or used to simulate them in vitro would be This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
interesting, a complex cell population is an unavoidable product of the surgical technique.
A limitation of this study regarding translation to an in vivo setting concerns the role of TGF-1. While TGF-1 has shown promise in combination with PDGF-BB in vitro, its use for in vivo application raises concerns, as active TGF-1 has been shown to induce fibrosis when injected into animal joints or delivered locally via scaffold, microparticle, or gene vector (1, 28, (81) (82) (83) . To avoid an adverse effect of TGF-1, one possibility is that moderate local activation of latent TGF-1 found in native synovial fluid by chemical or mechanical forces may provide the necessary cues to stimulate migration if combined with PDGF-BB (84, 85) . Alternatively, engineering approaches designed to locally deliver exogenous latent rather than active TGF-1 have shown promising preliminary results in rats (86) . A strong, local dose of a pro-chemotactic GF(e.g. PDGF-BB), however, may be sufficient to induce a chemotactic effect similar to that observed in vitro. An additional limitation of this study is the gel-to-gel experimental setup used in vitro as compared to the bone-to-gel geometry in vivo. This difference may result in altered cell migration kinetics, but may also be overcome by tuning the scaffold density or growth factor dose. Initial rabbit studies with KLD have demonstrated the capacity of the scaffold to support cell migration in vivo, and the work presented here suggests that the addition of chemotactic GFs may have the potential to increase cellularity in the defect (1) .
While the release of HB-IGF-1 from KLD may be too rapid in the geometry of IGF-1 has been shown to induce sustained production of aggrecan and collagen in chondrocyte-seeded RAD scaffolds, and is thus a promising candidate stimulant for generating repair tissue. Additionally, delivery of HB-IGF-1 from the scaffold to adjacent cartilage explant tissue in vitro has already been shown to stimulate chondrocyte biosynthesis within these explants (13) . Thus, HB-IGF-1 has the potential to stimulate repair and integration at the cartilage-scaffold interface. In this context, the KLD scaffold could provide local delivery of GFs such as HB-IGF-1 to the damaged cartilage interface, allowing HB-IGF-1 to serve its intended role as a pro-anabolic GF acting at the site of damage. Together, the ability of a scaffold to retain certain growth factors(e.g., PDGF-BB and TGF-1) while locally delivering others(e.g., HB-IGF-1)
demonstrates the dual role of such a hydrogel scaffold, and its capacity to be tailored to a particular tissue repair application.
V. CONCLUSIONS
This study demonstrates that the combination of PDGF-BB + TGF-1 has the capacity to accelerate progenitor cell migration into a 3D self-assembling peptide scaffold. Delivery of pro-anabolic GFs such as HB-IGF-1 may also stimulate cell biosynthesis within the scaffold and in adjacent cartilage tissue. We found that multiple growth factors with varying release kinetics can be delivered simultaneously in a single dose via the self-assembling peptide KLD. This multi-growth factor approach could be used to address multiple tissue regeneration challenges at once, including cell recruitment, tissue production, and integration. In the context of augmenting microfracture surgery for cartilage repair, our strategy of delivering chemotactic and proanabolic growth factors in KLD may provide the necessary local stimulus to help regenerate hyaline-like tissue. An extensive rabbit model is currently being used to test these results in vivo, though it is beyond the scope of this paper and will be presented in a detailed follow-up study.
VI.
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Figure captions
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This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. Fig. 7 : Release kinetics of PDGF-BB (n=14) and HB-IGF-1 (n=4) from KLD using their radiolabeled forms: The release of TGF-β1 (n=6), shown here for comparison, was previously published by Kopesky et al. (48) . By 4 days, when migration studies were terminated ( Fig 6) , 42% of the PDGF-BB and 84% of the TGF-β1 remained in the scaffold, whereas only 14% of the HB-IGF-1 was retained.
Supp. Fig. 1 : Experimental design for the release of GFs from KLD hydrogels to the medium: In the example of 125 I-PDGF-BB, free 125 I was removed by Sephadex G25 chromatography (as seen in fractions ~50-65). The remaining intact labeled 125 I-PDGF-BB (fractions ~20-30) was encapsulated in KLD hydrogels, and release to the PBS bath was measured using a gamma counter.
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